Prud'homme · Frontiers in aging 2022 · narrative review · n=?

Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations.

Cited 212 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review summarizing preclinical mechanisms and clinical associations without systematic methodology.

PubMed 35903083 · doi:10.3389/fragi.2022.931331 · record verified 2026-08-28

What was done

Narrative review examining the molecular biology, physiological functions, age-related pathological decline, and therapeutic upregulation strategies of the α-Klotho protein based on preclinical models and human clinical studies.

What was found

The abstract provides qualitative mechanistic descriptions without specific numerical data or effect sizes: - Klotho acts as an obligate coreceptor for FGF23 to regulate phosphate and vitamin D metabolism, as well as a soluble endocrine hormone (s-Klotho). - Klotho deficiency in mice causes shortened lifespan, multi-organ atrophy, fibrosis, and vascular/renal pathologies, whereas Klotho overexpression extends lifespan. - Klotho inhibits pro-aging pathways (TGF-β, IGF-1, Wnt, NF-κB) and upregulates antioxidant defenses via Nrf2 and FoxO. - Human Klotho levels decrease with age, chronic kidney disease, diabetes, and Alzheimer's disease, correlating with increased all-cause mortality. - Circulating Klotho is enhanced by exercise, certain pharmaceuticals (RAS inhibitors, fluvastatin, mTOR inhibitors, pentoxifylline, vitamin D, antidiabetics), and various nutraceuticals.

Why it matters

Synthesizes the biological mechanisms linking Klotho decline to multi-system aging pathologies and highlights potential pharmacological and lifestyle approaches to restore circulating Klotho.

Limits

The abstract describes a narrative overview rather than a systematic review or meta-analysis, reporting no search parameters, quantitative estimates, sample sizes, or quality assessments. Preclinical rodent findings are presented alongside human observational data without clear delineation of comparative clinical efficacy.

Cited by